Form 4 holding
Director, 10%+ Owner
BioXcel Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 8,546,750
- Estimated value
- $187,088,358
- Report date
- 06 Apr 2023
- Price
- $21.89
- Ownership
- Indirect
Krishnan Nandabalan - Director, 10%+ Owner at BioXcel Therapeutics, Inc.
Insider Transactions and Holdings
- Entity Type
- Individual
- Role
- Director, 10%+ Owner
- Issuer Symbol
- BTAI on Nasdaq
- All Insider Reports
- All Insider Reports
There are no Buy or Sell transactions made by Krishnan Nandabalan since 26 May 2025
Holdings reported by Krishnan Nandabalan for BioXcel Therapeutics, Inc.
Form 4 holding
Director, 10%+ Owner
BioXcel Therapeutics, Inc.
- Security class
- Stock Options
- Shares / value
- 294,000
- Estimated value
- Report date
- 06 Apr 2023
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
BioXcel Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 0
- Estimated value
- Report date
- 06 Apr 2023
- Price
- $21.89
- Ownership
- Direct
Transactions reported by Krishnan Nandabalan for BioXcel Therapeutics, Inc.
| Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.